Stay updated on INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial
Sign up to get notified when there's something new on the INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial page.

Latest updates to the INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3, indicating a minor backend update with no changes to the study details or user-facing content.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded an erratum reference for the Parkinson's disease burden article and removed the original Epub date/DOI from the Publications section.SummaryDifference0.1%

- Check20 days agoChange DetectedPublication reference for 'Non-motor features of Parkinson disease' updated to include the erratum; the earlier entry without the erratum was removed.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded a new site revision note (Revision: v3.4.2) and removed an outdated government funding lapse notice (and older revision v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now displays a site-wide notice about a lapse in government funding and NIH operations, and the site version has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedMinor UI and labeling updates include adding a 'Show glossary' option and standardizing capitalization on 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with updating the revision label to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial page.